AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2014

Nov 25, 2014

32870_dirs_2014-11-25_df59f5ff-c52d-4fd0-b244-19c3c4345cc1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2014-11-25

Reporting Person: Harsanyi Zsolt (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-25	Common Stock	M	8000	$11.67	Acquired	27100	Direct
2014-11-25	Common Stock	S	8000	$24.82	Disposed	19100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-25	Stock Option	$11.67	M	8000	Disposed	2019-05-21	Common Stock (8000)	Direct

Footnotes

F1: Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.75 to $24.94, inclusive.

F3: The option vested in three equal installments on May 21, 2010, 2011 and 2012.